adaptive trial design
Digital disruption in clinical trials
April 13 by Joyce El HokayemHuman Genetics Scientist, Joyce El Hokayem examines where the digital era is taking today’s clinical trials.
The Failure Rate at Phase Three is Probably 70% or Greater
April 25 by Surya Chitra, PhD, MBA, Biostatistics and Pharmacology, and Gary Fishbein, MD, MPH,Surya Chitra, PhD, MBA, Biostatistics and Pharmacology, and Gary Fishbein, MD, MPH, Senior Medical Director, PharmaNet Development Group, Inc, join Pharma IQ to discuss adaptive trial design. Pharma...